Park SH - Search Results

1

Immunoreactivity of CD99 in stomach cancer.

Jung KC, Park WS, Bae YM, Hahn JH, Hahn K, Lee H, Lee HW, Koo HJ, Shin HJ, Shin HS, Park YE, Park SH. Jung KC, et al. Among authors: park ws, park ye, park sh. J Korean Med Sci. 2002 Aug;17(4):483-9. doi: 10.3346/jkms.2002.17.4.483. J Korean Med Sci. 2002. PMID: 12172043 Free PMC article.

2

Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells.

Lee HJ, Kim E, Jee B, Hahn JH, Han K, Jung KC, Park SH, Lee H. Lee HJ, et al. Among authors: park sh. Exp Mol Med. 2002 Jul 31;34(3):177-83. doi: 10.1038/emm.2002.26. Exp Mol Med. 2002. PMID: 12216109

3

The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat.

Jung KC, Kim NH, Park WS, Park SH, Bae Y. Jung KC, et al. Among authors: park ws, park sh. FEBS Lett. 2003 Nov 20;554(3):478-84. doi: 10.1016/s0014-5793(03)01224-9. FEBS Lett. 2003. PMID: 14623115 Free article.

4

Mutations of the immunoglobulin heavy chain variable region gene in CD99-deficient BJAB cell line.

Suh YH, Kim MK, Shin YK, Kim SH, Oh KI, Gil M, Kim MK, Choi YL, Jung KC, Lee KM, Lee IS, Park SH. Suh YH, et al. Among authors: park sh. Mol Cells. 2002 Apr 30;13(2):237-44. Mol Cells. 2002. PMID: 12018845 Free article.

5

Characterization and epitope mapping of two monoclonal antibodies against human CD99.

Gil MC, Lee MH, Seo JI, Choi YL, Kim MK, Jung KC, Park SH, Kim TJ. Gil MC, et al. Among authors: park sh. Exp Mol Med. 2002 Dec 31;34(6):411-8. doi: 10.1038/emm.2002.58. Exp Mol Med. 2002. PMID: 12526082

6

MHC class II engagement inhibits CD99-induced apoptosis and up-regulation of T cell receptor and MHC molecules in human thymocytes and T cell line.

Kim MK, Choi YL, Kim MK, Kim SH, Choi EY, Park WS, Bae YM, Woo SK, Park SH. Kim MK, et al. Among authors: park ws, park sh. FEBS Lett. 2003 Jul 10;546(2-3):379-84. doi: 10.1016/s0014-5793(03)00567-2. FEBS Lett. 2003. PMID: 12832073 Free article.

7

Rapid divergency of rodent CD99 orthologs: implications for the evolution of the pseudoautosomal region.

Park SH, Shin YK, Suh YH, Park WS, Ban YL, Choi HS, Park HJ, Jung KC. Park SH, et al. Among authors: park ws, park hj. Gene. 2005 Jul 4;353(2):177-88. doi: 10.1016/j.gene.2005.04.023. Gene. 2005. PMID: 15978751

8

A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.

Byun HJ, Hong IK, Kim E, Jin YJ, Jeoung DI, Hahn JH, Kim YM, Park SH, Lee H. Byun HJ, et al. Among authors: park sh. J Biol Chem. 2006 Nov 17;281(46):34833-47. doi: 10.1074/jbc.M605483200. Epub 2006 Sep 19. J Biol Chem. 2006. PMID: 16984917 Free article.

9

CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta.

Oh KI, Kim BK, Ban YL, Choi EY, Jung KC, Lee IS, Park SH. Oh KI, et al. Among authors: park sh. Exp Mol Med. 2007 Apr 30;39(2):176-84. doi: 10.1038/emm.2007.20. Exp Mol Med. 2007. PMID: 17464179

10

Interaction between the mouse homologue of CD99 and its ligand PILR as a mechanism of T cell receptor-independent thymocyte apoptosis.

Park HJ, Ban YL, Byun D, Park SH, Jung KC. Park HJ, et al. Among authors: park sh. Exp Mol Med. 2010 May 31;42(5):353-65. doi: 10.3858/emm.2010.42.5.037. Exp Mol Med. 2010. PMID: 20208422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,108 results

Search Page

Filters